Filing Details
- Accession Number:
- 0001104659-20-113680
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-09 08:09:25
- Reporting Period:
- 2020-10-07
- Accepted Time:
- 2020-10-09 08:09:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1356090 | Precigen Inc. | PGEN | Services-Commercial Physical & Biological Research (8731) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1720283 | S.a. Trading Ares | Zone Industrielle De L'Ouriettaz Aubonne V8 1170 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-10-07 | 6,758,400 | $3.70 | 27,398,519 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- On October 7, 2020, Ares Trading S.A. converted all of the $25,000,000 outstanding principal amount of the Convertible Note issued to Ares Trading S.A. (as described in Footnote (1) to the Form 3 filed by the reporting persons on January 22, 2019) into 6,758,400 shares of Common Stock of the Issuer at a conversion price of $3.6991 per share, reflecting the volume weighted-average price per share of the Common Stock on the Nasdaq Stock Market for the consecutive ten trading days immediately prior to the conversion date.